Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-08-22

Clinical Trial Update: Curcumin's Effect on Diabetic Patients With Atherosclerotic Cardiovascular Risk [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial at Ain Shams University evaluated curcumin in adults with type 2 diabetes and dyslipidemia/hypertension at risk for atherosclerotic car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Curcumin (curcumin)

Snippet

Sponsor: Ain Shams University | Conditions: Diabetes Mellitus, Type 2, Dyslipidemias | Phase 2 | Status: COMPLETED